CT、磁共振定量诊断肝纤维化的研究进展

严福华; 罗先富

doi:10.3969/j.issn.1001-5256.2013.10.003

CT、磁共振定量诊断肝纤维化的研究进展

DOI: 10.3969/j.issn.1001-5256.2013.10.003

上海交通大学医学院附属瑞金医院放射科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3202
- HTML全文浏览量: 21
- PDF下载量: 787
- 被引次数: 0
出版历程
- 收稿日期: 2013-07-22
- 出版日期: 2013-10-20

Research progress in CT and MR for quantitative diagnosis of liver fibrosis

Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

摘要

摘要: 肝纤维化是肝脏对各种病因所致的肝损伤的修复愈合反应,也是各种慢性肝病向肝硬化发展的中间阶段。肝纤维化发展过程是潜隐渐进而可逆的。肝纤维化能否得到及时和正确的诊断,对临床治疗效果及患者预后有着重要的意义。随着影像技术的发展完善,肝纤维化的无创性影像定量诊断备受临床关注。总结了目前用于肝纤维化诊断的各种CT、磁共振(MR)扫描技术,就各种技术的优缺点进行了比较。结果表明CT、MR可对肝纤维化进行定量评估,尤其MR无辐射、高分辨率、可重复性好在将来完全有可能取代有创的病理检查。
- 肝硬化 /
- 体层摄影术,X线计算机 /
- 磁共振波潽学
Abstract: Liver fibrosis is a repair response to liver damage caused by various factors, as well as an intermediate stage between chronic liver diseases and liver cirrhosis. The development of liver fibrosis is a latent, gradual, and reversible process. Timely, accurate diagnosis of liver fibrosis is of great significance for the treatment outcome and prognosis of patients. With the development of imaging techniques, noninvasive quantitative diagnosis of liver fibrosis has attracted more and more attention. Various techniques of CT and MR for diagnosis of liver fibrosis are summarized, and the advantages and disadvantages are compared between these techniques. Our results show that CT and MR can be used for quantitative assessment of liver fibrosis and that MR is very likely to be used instead of invasive biopsy in the future due to its advantages of no radiation, high resolution, and good repeatability.
- liver cirrhosis /
- tomography, X-Ray computed /
- magnetic resonance spectroscopy

HTML全文

参考文献(30)

[1]DESMET VJ, ROSKAMS T.Cirrhosis reversal:a duel between dogma and myth[J].J Hepatol, 2004, 40 (5) :860-867.

[2]LEFTON HB, ROSA A, COHEN M.Diagnosis and epidemiology of cirrhosis[J].Med Clin North Am, 2009, 93 (4) :787-799.

[3]BEDOSSA P, POYNARD T.An algorithm for the grading of activity inchronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.

[4]ROMERO-GMEZ M, GMEZ-GONZLEZ E, MADRAZO A, et al.Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C[J].Hepatology, 2008, 47 (3) :810-816.

[5]TAURA T, NAKAMURA K, TAKASHIMA S, et al.Heterogeneity of hepatic parenchymal enhancement on computed tomography during arterial portography:quantitative analysis of correlation with severity of hepatic fibrosis[J].Hepatol Res, 2001, 20 (2) :182-192.

[6]NAKAURA T, NAKAMURA S, MARUYAMA N, et al.Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT:effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality[J].Radiology, 2012, 264 (2) :445-454.

[7]COULON S, HEINDRYCKX F, GEERTS A, et al.Angiogenesis in chronic liver disease and its complications[J].Liver Int, 2011, 31 (2) :146-162.

[8]ZHONG L, WANG WJ, XU JR, et al.Clinical application of hepatic CT perfusion[J].World J Gastroenterol, 2009, 15 (18) :907-911.

[9]RONOT M, ASSELAH T, PARADIS V, et al.Liver fibrosis in chronic hepatitis C virus infection:differentiating minimal from intermediate fibrosis with perfusion CT[J].Radiology, 2010, 256 (1) :135-142.

[10]VILLENEUVE JP, DAGENAIS M, HUET PM, et al.The hepatic microcirculation in the isolated perfused human liver[J].Hepatology, 1996, 23 (1) :24-31.

[11]SAHIN S, ROWLAND M.Estimation of aqueous distributional spaces in the dual perfused rat liver[J].J Physiol, 2000, 528 (Pt1) :199-207.

[12]VARENIKA V, FU Y, MAHER JJ, et al.Hepatic fibrosis:evaluation with semiquantitative contrast-enhanced CT[J].Radiology, 2013, 266 (1) :151-158.

[13]YAN FH.Paying attention to quantitative study and clinical application of new techniques of abdominal CT and MR[J].Chin J Radiol, 2013, 47 (2) :101-103. (in Chinese) 严福华.重视腹部CT和MR新技术的量化研究和临床应用[J].中华放射学杂志, 2013, 47 (2) :101-103.

[14]LYU P, LIN X, GAO J, et al.Spectral CT:preliminary studies in the liver cirrhosis[J].Korean J Radiol, 2012, 13 (4) :434-442.

[15]MACARINI L, MARINI S, MILILLO P, et al.Double-contrast MRI (DCMRI) in the study of the cirrhotic liver:utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptakeand distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions[J].Radiol Med, 2006, 111 (8) :1087-1102.

[16]AGUIRRE DA, BEHLING CA, ALPERT E, et al.Liver fibrosis:noninvasive diagnosis with double contrast material-enhanced MR imaging[J].Radiology, 2006, 239 (2) :425-437.

[17]NISHIE A, ASAYAMA Y, ISHIGAMI K, et al.MR prediction of liver fibrosis using a liver-specific contrast agent:Superparamagnetic iron oxide versus Gd-EOB-DTPA[J].J Magn Reson Imaging, 2012, 36 (3) :664-671.

[18]NORéN B, FORSGREN MF, DAHLQVIST LEINHARD O, et al.Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA[J].Eur Radiol, 2013, 23 (1) :174-181.

[19]MOTOSUGI U, ICHIKAWA T, SANO K, et al.Magnetic resonance elastography of the liver:preliminary results and estimation of inter-rater reliability[J].Jpn J Radiol, 2010, 28 (8) :623-627.

[20]SHIRE NJ, YIN M, CHEN J, et al.Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C[J].J Magn Reson Imaging, 2011, 34 (4) :947-955.

[21]YOON JH, LEE JM, WOO HS, et al.Staging of hepatic fibrosis:comparison of magnetic resonance elastography and shear wave elastography in the same individuals[J].Korean J Radiol, 2013, 14 (2) :202-212.

[22]WANG QB, ZHU H, LIU HL, et al.Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:a meta-analysis[J].Hepatology, 2012, 56 (1) :239-247.

[23]LUCIANI A, VIGNAUD A, CAVET M, et al.Liver cirrhosis:intravoxel incoherent motion MR imaging-pilot study[J].Radiology, 2008, 249 (3) :891-899.

[24]DYVORNE HA, GALEA N, NEVERS T.Diffusion-weighted imaging of the liver with multiple b values:effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study[J].Radiology, 2013, 266 (3) :920-929.

[25]HAGIWARA M, RUSINEK H, LEE VS, et al.Advanced liver fibrosis:diagnosis with 3D whole-liver perfusion MR imaging-initial experience1[J].Radiology, 2008, 246 (3) :926-934.

[26]NOREN B, DAHLQVIST O, LUNDBERG P, et al.Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy[J].Eur J Radiol, 2008, 66 (2) :313-320.

[27]WONG VW, CHU WC, WONG GL, et al.Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese:a population study using proton-magnetic resonance spectroscopy and transient elastography[J].Gut, 2012, 61 (3) :409-415.

[28]POLASEK M, FUCHS BC, UPPAL R, et al.Molecular MR imaging of liver fibrosis:a feasibility study using rat and mouse models[J].J Hepatol, 2012, 57 (3) :549-555.

[29]CHOW AM, TAN M, GAO DS, et al.Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model[J].Invest Radiol, 2013, 48 (1) :46-54.

[30]BALASSY C, FEIER D, PECK-RADOSAVLJEVIC M, et al.Susceptibility-weighted MR imaging in the grading of liver fibrosis:a feasibility study[J].Radiology, 2013.[Epub ahead of print]

施引文献

资源附件(0)

访问统计